Vitiligo is an acquired pigmentary disorder of unknown etiology that is clinically
characterized by the development of white macules related to the selective loss of …

Background Patients with vitiligo experience reduced quality of life. Objective To
comprehensively describe the available evidence for psychosocial burden in vitiligo …

Despite historical mischaracterization as a cosmetic condition, patients with the autoimmune
disorder vitiligo experience substantial quality‐of‐life (QoL) burden. This systematic …

Vitiligo is a common depigmenting disorder with profound psychosocial impacts. Previous
observational studies have suggested a link between vitiligo and psychiatric morbidity, such …

BACKGROUND: Vitiligo significantly affects a person's health-related quality of life (HRQL).
Although a small number of generic, and disease-specific, dermatologic HRQL measures …

Background Vitiligo is a chronic disorder causing skin depigmentation with global
prevalence varying from 0· 2% to 1· 8%. UK guidelines recommend assessment of …

Vitiligo significantly affects quality of life (QOL) in adults, but little is known about the effect on
QOL of pediatric vitiligo and whether the extent, distribution, and duration of vitiligo are …

Background Vitiligo is a common chronic autoimmune disease that is characterized by
progressive loss of skin color due to melanocyte destruction. In addition to the physical …

Introduction To date, no formal study has been published regarding how Colombian patients
with skin disorders could be affected according to their perception of disease. Objective To …

Objective The objective of this study was to provide a pooled estimate of the prevalence and
odds of depression in patients with vitiligo. Methods A systematic literature search of …